TRVI Competitors & Alternatives
Compare Trevi Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRVI
Main Stock$14.82
Tradestie Score
24
Market Cap
$1.14B
Analyst Upside
+90.2%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.59
|
$2.23B | - | 50 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.94
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.04
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.73
|
$2.18B | - | 49 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.65
|
$2.08B | - | 44 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.68
|
$2.02B | 821.0 | 31 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.41
|
$2.01B | - | 41 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$29.40
|
$1.97B | - | 38 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.66
|
$1.92B | - | 59 | Compare |
More TRVI Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry